2023 international evidence-based guideline pcos glp-1 receptor agonist The dual impact of agonists on metabolic and reproductive health in polycystic ovary syndrome: insights from human and animal trials Research progress on insulin resistance

Weight Loss Drug Comparison: Efficacy, Muscle Loss, and Market Stage Towards a Dual-Action Approach: Fat Loss and Muscle Preservation Recognizing the need for a more balanced approach to weight management, pharmaceutical innovators are now focusing on therapies that not only promote fat loss but also preserve or enhance muscle mass (Rodgers and Christopher 2022)

Conversely, a study by Gasbjerg et al

Deanfield J, Verma S, Scirica BM, Kahn SE, Emerson SS, Ryan D, et al

The absence of a control group precludes definitive conclusions on causality between GLP-1 receptor agonist therapy and observed outcomes, and residual confounding cannot be excluded In conclusion, arGLP-1 represent a valuable addition to the therapeutic arsenal for managing IWL or WR after BS

In rare cases, GLP-1 agonists may cause serious side effects, including allergic reactions, pancreatitis, gallbladder disease, and kidney disease.[ref][ref] Obviously, talk with your doctor about the risks vs